v3.25.1
STOCKHOLDERS’ EQUITY / (DEFICIT) (Tables)
3 Months Ended 12 Months Ended
Mar. 31, 2025
Dec. 31, 2024
Equity [Abstract]    
SCHEDULE OF OUTSTANDING PREPAID WARRANTS AND COMMON WARRANTS

The following sets forth the outstanding prepaid warrants and common warrants as of March 31, 2025:

 

   Prepaid Warrants   Common Warrants 
Balance December 31, 2024   3,871,992    382,205 
Exercise of Prepaid Warrants in Exchange for Common Stock   (1,252,559)    
Balance March 31, 2025   2,619,433    382,205 

The following sets forth the outstanding prepaid warrants and common warrants for the years ended December 31, 2024 and 2023:

 

   Prepaid Warrants   Common Warrants 
Balance December 31, 2022        
Conditional issuance of Prepaid Warrants from Exchange of 2022 and 2023 Convertible Notes   507,394     
Balance December 31, 2023   507,394     
Conditional Issuance of Prepaid Warrants from Exchange of Whiskey Notes   546,927     
Conditional Issuance of Prepaid Warrants in Exchange for Common Stock   2,816,291     
Exercise of Prepaid Warrants in Exchange for Common Stock   (698,619)    
Issuance of Prepaid Warrants for Common Stock   700,001     
November 25, 2024 Private Placement of Common Warrants       382,205 
Balance December 31, 2024   3,871,992    382,205 
SCHEDULE OF OUTSTANDING ISOS AND RELATED ACTIVITY

The following sets forth the outstanding ISOs and related activity for the three months ended March 31, 2025:

 

Options Outstanding 

Number of

Shares

  

Weighted-

Average

Exercise Price

Per Share

  

Weighted-

Average

Remaining

Contractual

Term (in years)

  

Aggregate

Intrinsic Value

 
Outstanding at December 31, 2024   6,011   $157.89    0.86   $0.00 
Exercisable at December 31, 2024   6,011   $157.89    0.86   $0.00 
Forfeited   0   $157.89           
Outstanding at March 31, 2025   6,011   $157.89    0.61   $0.00 
Exercisable at March 31, 2025   6,011   $157.89    0.61   $0.00 
Remaining unvested at March 31, 2025      $157.89           

The following sets forth the outstanding ISOs and related activity for the years ended December 31, 2024 and 2023:

 

Options Outstanding 

Number of

Shares

  

Weighted-

Average

Exercise Price

Per Share

  

Weighted-

Average

Remaining

Contractual

Term (in years)

  

Aggregate

Intrinsic Value

 
Outstanding at December 31, 2022   8,137   $157.89    2.82   $0.00 
Forfeited   (1,959)  $157.89           
Outstanding at December 31, 2023   6,178   $157.89    1.86   $0.00 
Exercisable at December 31, 2023   6,178   $157.89    1.86   $0.00 
Forfeited   (167)  $157.89           
Outstanding at December 31, 2024   6,011   $157.89    0.86   $0.00 
Exercisable at December 31, 2024   6,011   $157.89    0.86   $0.00 
Remaining unvested at December 31, 2024      $157.89           
SUMMARY OF RSU’s

The following table summarizes the RSU activity for the three months ended March 31, 2025 and 2024:

 

  

Restricted

Stock

Units

  

Weighted Average

Exercise Price

Per Share

 
Vested and Outstanding at December 31, 2024   245,589   $10.93 
Granted         
Forfeited/Canceled/Expired   (150     
Vested and Outstanding at March 31, 2025   245,439   $10.93 

The following table summarizes the RSU activity for the years ended December 31, 2024 and 2023:

 

  

Restricted

Stock

Units

  

Weighted Average

Exercise Price

Per Share

 
Unvested and Outstanding at December 31, 2022   105,727   $157.89 
Granted   14,015   $157.89 
Forfeited/Canceled/Expired   (2,798)  $157.89 
Unvested and Outstanding at December 31, 2023   116,944   $157.89 
Granted   234,525   $4.00 
Forfeited/Canceled/Expired   (105,880)  $157.89 
Vested and Outstanding at December 31, 2024   245,589   $10.93 
SCHEDULE OF VALUATION ASSUMPTIONS

 

Weighted Average Expected Volatility   70%
Expected Dividends   %
Weighted Average Expected Term (in years)   5 
Risk-Free Interest Rate   4.22%
Probability Scenarios of meeting contingencies     
Shareholder holds shares owned on May 31, 2023 through warrant exercise date   95% to 75%
Common stock attains a specified 10-Trading-Day VWAP price before expiring   0.025% to 2.25%
 
  

For the Three Months Ended

March 31, 2025

  

For the Year Ended

December 31, 2024

 
Weighted Average Expected Volatility   70%   70%
Expected Dividends   %    % 
Weighted Average Expected Term (in years)   5    5 
Risk-Free Interest Rate   4.12%   4.22%
 

 

  

For the Years Ended

December 31,

 
   2024   2023 
Weighted Average Expected Volatility   70%    
Expected Dividends   %    
Weighted Average Expected Term (in years)   5     
Risk-Free Interest Rate   4.22%    
Probability Scenarios of meeting contingencies          
Shareholder holds shares owned on May 31, 2023 through warrant exercise date   95% to 75%     
Common stock attains a specified 10-Trading-Day VWAP price before expiring   0.025% to 2.25%     
  
  

For the Years Ended

December 31,

 
   2024   2023 
Weighted Average Expected Volatility   70%    
Expected Dividends   %    
Weighted Average Expected Term (in years)   5     
Risk-Free Interest Rate   4.22%    
 
SCHEDULE OF STOCK BASED COMPENSATION EXPENSE INCLUDED IN THE CONSOLIDATED STATEMENTS OF OPERATIONS RELATED TO ISOs ISSUED  

The following table presents stock-based compensation expense included in the consolidated statements of operations related to ISOs issued under the 2019 Plan:

 

   2024   2023 
  

For the Twelve Months Ended

December 31,

 
   2024   2023 
Cost of Sales  $   $ 
Sales and Marketing        
General and Administrative       18,595 
Total Share-based Compensation  $   $18,595 
SCHEDULE OF EQUITY-BASED (NON-CASH) COMPENSATION FOR EMPLOYEES (PERSONNEL) AND CONSULTANTS  

 

   2024   2023 
   Years Ended December 31, 
   2024   2023 
Production / Cost of Sales  $178,140   $ 
Sales and Marketing   729,592     
General and Administrative   2,414,097    6,028 
Subtotal Employee Compensation   3,321,829    6,028 
Professional Fees (General and Administrative)   1,570,281    12,566 
Total Non-Cash Share-Based Compensation  $4,892,110   $18,594